Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ONCSQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
January 31, 2023 8.871M
October 31, 2022 14.44M
July 31, 2022 21.88M
April 30, 2022 27.99M
January 31, 2022 35.09M
October 31, 2021 45.62M
July 31, 2021 56.28M
April 30, 2021 63.63M
January 31, 2021 70.01M
October 31, 2020 33.92M
July 31, 2020 29.90M
April 30, 2020 39.14M
January 31, 2020 19.79M
October 31, 2019 23.25M
July 31, 2019 29.89M
April 30, 2019 26.99M
January 31, 2019 32.22M
October 31, 2018 32.18M
July 31, 2018 30.25M
April 30, 2018 37.06M
January 31, 2018 22.12M
October 31, 2017 18.70M
July 31, 2017 15.23M
April 30, 2017 19.97M
January 31, 2017 24.31M
Date Value
October 31, 2016 28.09M
July 31, 2016 32.41M
April 30, 2016 28.27M
January 31, 2016 32.93M
October 31, 2015 30.40M
July 31, 2015 35.59M
April 30, 2015 27.64M
January 31, 2015 32.72M
October 31, 2014 35.72M
July 31, 2014 39.39M
April 30, 2014 25.70M
January 31, 2014 19.79M
October 31, 2013 17.05M
July 31, 2013 6.510M
April 30, 2013 8.874M
January 31, 2013 10.71M
October 31, 2012 5.516M
July 31, 2012 7.429M
April 30, 2012 8.806M
January 31, 2012 2.985M
October 31, 2011 4.143M
July 31, 2011 5.674M
April 30, 2011 3.553M
January 31, 2011 0.0053M
October 31, 2010 0.0002M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M